Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on 11 July, 2019. The fund is managed by Dhaval Shah. The fund could potentially beat inflation in the long-run.
1) Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has a NAV of 19.53 as on 04-Dec-2021.
2) Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has 567 Cr worth of assets under management (AUM) as on 04-Dec-2021 and is less than category average.
3) The fund has an expense ratio 1.12 %.
|S&P BSE Healthcare PR|
|11 July, 2019|
Dhaval Shah is MBA in Finance, Mumbai University; Holds CFA Charter.
14 Years experience
DSP Healthcare Fund Direct Growth
33.39% (3 Yrs)
Mirae Asset Healthcare Fund Direct Growth
32.46% (3 Yrs)
SBI Healthcare Opportunities Fund Direct Growth
23.46% (3 Yrs)
Nippon India Pharma Fund - Direct Plan - Growth Plan
26.53% (3 Yrs)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
27.37% (3 Yrs)
Frequently Asked Questions